Abstract:GlycoproteinVI (GPVI ), one of the platelet collagen receptors, plays an important role in platelet activation and thrombosis. GPVI participates in platelet adhesion to exposed collagen under high shear rate condition, and leads to platelet activation and thrombus formation. GPVI is widely recognized as a requisite factor for the formation of platelet aggregates on the collagen surface under blood flow. There were growing evidences showed that impairment of GPVI function could result in a long-term antithrombotic protection and less bleeding side-effect, which potentialized that GPVI might be an interesting target for safe anti-adhesion and anti-thrombotic therapy. Recently monoclonal antibodies directed against GPVI were developed, which impaired the interaction of platelets and collagen. A human soluble recombinant GPVI (rGPVI), consisting of extracellular domain of GPVI, was expressed in E. coli. After immunizing Balb/C mice with the purified rGPVI, a monoclonal antibody, SZ118, was developed. Meanwhile the gene encoding for the light-and heavy-chain variable regions of SZ118 had been cloned by RT-PCR from murine hybridoma cells. After ligated into the vector pET20b(+), expression plasmid pET20b(+)-SZ118-scFv was contructed, and SZ118-scFv fragment was expressed in E.coli. The parallel plate perfusion chamber and platelet aggregometer were used to study the effects of SZ118 and SZ118-scFv on the platelet adhesion and aggregation to collagen. The citrated whole blood with or without SZ118 was perfused over the surface of type I fibrillar collagen (Chrono Log, at 80μg/ml) at high shear rate (1000 s−1) for 5 min. The platelet aggregates were visualized by the phase-contrast microscope, the coverage rates of the platelet aggregates were measured. Monoclonal antibody SZ118 and SZ118-scFv could bind to human platelets exclusively by flow cytometry. SZ118 inhibited collagen-induced platelet aggregation in PRP in dose-dependent manner, nearly full inhibition being attained at the concentration of 110 ug•mL−1. Similarly SZ118-scFv inhibited collagen-induced platelet aggregation with maximum inhitition rate 84.3%±5.6%. And also SZ118 and SZ118-scFv had part effect on convulxin-induced platelet aggregation, but having little effect on ADP. After treating the citrated whole blood with SZ118 or SZ118-scFv at final concentration 50μg/ml at 37° for 10 min, the platelet adhesion on the surface of collagen was markedly inhibited with the coverage rates of 1.03%±0.22%, respectively (22.7%±5.7% for control), which indicated that the platelets adhesion to collagen was inhibited by 95.5%by SZ118 and 68.3% by SZ118-scFv. It was concluded that the MoAb SZ118 inhibited platelet aggregation to collagen and platelet adhesion to immobilized fibrillar collagen under high shear rate condition.

Study on epitope and function of a novel monoclonal antibody against platelet factor 4

Preparation and Identification of a Monoclonal Antibody Against Human Platelet Factor 4 by Intrasplenic Immunization

Expression and characterization of the ScFv fragment of antiplatelet GPIIIa monoclonal antibody SZ-21.

Development,identification and Function Assay of Monoclonal Antibody Against Platelet Membrane Glycoprotein Ib

Development of a monoclonal antibody to factor ⅧC2 domain and its functional study

Construction and expression of a single chain antibody fragment of mAb SZ-21 against platelets GPⅢa

[Studies on the antithrombotic effects of anti-platelet mAb SZ-21 F(ab')(2) fragment].

Monoclonal anti-glycoprotein Ib thrombin receptor antibody:its preparation and study on its function

Preparation and Characterization of a Single Chain Antibody of McAb SZ118 Against Platelet Glycoprotein VI

Defining an Antigenic Epitope on Platelet Factor 4 Associated with Heparin-Induced Thrombocytopenia

[Construction and Expression of Mouse-Human Chimeric Fab Fragment Gene of Monoclonal Antibody SZ-2 Against Platelet].

[Construction and Characterization of Bispecific Single-Chain Antibody Fragments SZ-2/SZ-21 Against Platelet Glycoprotein Ib Alpha and Beta3].

Epitope Mapping of Human VWF A3 Recognized by Monoclonal Antibody SZ-123 and SZ-125 Using MALDI Mass Spectrometry

[Eukaryotic Expression and Determination of ZCH-7-2F9 Single Chain Antibody Against Human CD14].

Platelet factor 4 binding to lipid A of Gram-negative bacteria exposes PF4/heparin-like epitopes

Preparation and Charaterization of Moab Sz118 and Sz118-Scfv Against Platelet Glycoprotein Vi.

Affinity maturation and characterization of a human monoclonal antibody against HIV-1 gp41.

Engineering and Characterization of A Chimeric Anti-Platelet Glycoprotein Ib Alpha Monoclonal Antibody and Preparation of Its Fab Fragment

Development of a novel monoclonal antibody to B7-H4: characterization and biological activity

[Preparation and Characterization of a Single Chain Antibody Fragment of Mab SZ-21 Against Platelets GPIIIa].

Engineering and Characterization of a Chimeric Anti-platelet Glycoprotein Ibα Monoclonal Antibody and Preparation of Its Fab Fragment